Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02793778Phase 2Terminated
Phase 2, randomised, double-blind trial (2 arms), sponsored by Prometheus Laboratories. Primary endpoint: Simple Endoscopic Score - Crohn's Disease at 24 weeks. Started Jul 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02793778.